Premium
Successful treatment of lymph node metastases recurring from gallbladder cancer
Author(s) -
Tasaki Kentaro,
Yamamoto Hiroshi,
Watanabe Kazuo,
Asano Takehide,
Honda Ichiro,
Watanabe Satoshi,
Nagata Matsuo,
Soda Hiroaki,
Shimizu Yasuhito,
Tohma Takayuki
Publication year - 2003
Publication title -
journal of hepato‐biliary‐pancreatic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.63
H-Index - 60
eISSN - 1868-6982
pISSN - 0944-1166
DOI - 10.1007/s10534-002-0819-3
Subject(s) - medicine , lymph node , gallbladder cancer , gallbladder , cholecystectomy , lymphadenectomy , radiology , metastasis , positron emission tomography , cancer recurrence , cancer , surgery
A 66‐year‐old woman who had undergone cholecystectomy for the treatment of gallbladder cancer 5 years and 10 months previously was referred to our center due to increased carbohydrate antigen (CA)19‐9. Increased CA19‐9 (136 U/ml) was the only abnormality detected on initial examination, and, despite various tests, clear signs of recurrence could not be detected. Subsequently, the patient was followed. Six months after the initial examination, dynamic computerized tomography confirmed lymphadenopathy. The results of fluoro‐deoxy‐glucose positron emission tomography suggested lymph node metastasis of the gallbladder cancer, and after consideration of the site of recurrence and the length of time between the primary surgery and detection of recurrence, the patient underwent extrahepatic bile duct resection and lymphadenectomy. Levels of CA19‐9 normalized postoperatively, and, at the time of writing (26 months postoperatively), blood tests and diagnostic imaging revealed no signs of recurrence.